Human Biomonitoring
The measurement of chemical substances, their metabolites, or markers of health effects in human specimens (such as blood or urine) to assess exposure levels and potential health risks, informing regulatory priorities and the effectiveness of restrictions.
Foresight tracks Human Biomonitoring developments and surfaces the alerts most likely to matter before they turn into missed deadlines, recalls, or escalation work.
Current activity
Cooling
31% below the prior 8-week baseline
3-month trend
Latest alerts below
Last updated
6 April 2026, 19:03
Latest Human Biomonitoring alerts
The most recent regulatory and guidance signals tracked by Foresight
RIVM and Partners Develop Human PBK Model for PFOA to Support PFAS Risk Assessment
Researchers have released a next-generation human kinetic model for PFOA, enabling high-precision risk assessments without animal testing. This methodology facilitates more granular, organ-specific PFAS toxicity modeling, likely driving the adoption of more stringent health-based guidance values and accelerated regulatory restrictions.
Global Public Health Experts Issue Seattle Statement Urging Stricter Glyphosate Regulation
Global health experts have issued the Seattle Statement calling for stricter regulation or elimination of glyphosate due to systemic health risks. This intensifies pressure on regulators to overhaul pesticide risk assessments and signals heightened litigation and market access risks for glyphosate-based products.
Netherlands Ministry of Health Answers Chemelot Health Questions and Plans Decision on National Biomonitoring Programme
The Dutch government will decide on a national chemical biomonitoring programme by summer 2026 to address public health concerns around major industrial clusters. This initiative, alongside new frameworks for assessing industrial health costs, signals a long-term shift toward stricter emission controls and enhanced liability risks for chemical manufacturers.
Great Britain HSE Consults On Lower Blood Lead Action and Suspension Levels Under Control of Lead at Work Regulations 2002
The UK HSE has proposed a major tightening of blood-lead limits for workers, with phased implementation of significantly lower action and suspension levels starting in October 2027. Companies handling lead must evaluate current exposure controls and medical surveillance programs, as the proposed thresholds represent a substantial shift in occupational health compliance requirements.
France (ANSES) Calls For Cadmium Limits In Fertilisers To Address Food Overexposure
France’s ANSES has called for immediate regulatory action to lower cadmium limits in fertilizers and food following findings of significant population overexposure. Companies in the fertilizer and food sectors should prepare for stricter concentration limits and enhanced labeling requirements, requiring urgent supply chain assessments for high-risk inputs.
US Study Links PFOS Exposure to Slower Processing Speed in Firefighters
New research links PFOS exposure from firefighting gear and foam to reduced cognitive processing speed in first responders. This evidence supports the transition toward PFAS-free protective equipment and may drive more stringent occupational health surveillance and chemical risk assessments.
Exposure to PFAS and Inflammatory Bowel Disease: Review and Meta-Analysis
A March 2026 peer-reviewed meta-analysis links PFOA exposure to increased inflammatory bowel disease risk and identifies PFDA as a significant regulatory gap in US drinking water standards. This emerging epidemiological evidence increases the likelihood of expanded federal PFAS restrictions and may bolster future litigation and hazard-based classification efforts.
EFSA Publishes 2025 Annual Report of the Advisory Group on Biomarkers of Effect
EFSA published its 2025 annual report on biomarkers of effect in March 2026, advancing methodological frameworks for chemical risk assessment. These developments signal a shift toward more sophisticated, effect-based monitoring that will likely influence future safety thresholds and cumulative risk evaluations.
Journal of the Endocrine Society Study Links Early-Life PFAS Exposure to Lower Adolescent Bone Density
A March 2026 study in the *Journal of the Endocrine Society* links early-life PFAS exposure to significantly lower bone mineral density in adolescents. This finding establishes bone health as a critical toxicological endpoint, likely accelerating regulatory pressure to restrict PFAS in consumer products.
Global Framework on Chemicals Launches 2026 Baseline Data Collection Survey (Closes 24 April 2026)
The Global Framework on Chemicals (GFC) has launched a baseline data collection survey, open until April 24, 2026, to establish indicators for tracking global chemicals and waste management progress. Participation offers industry stakeholders an early opportunity to influence the metrics used for future global reporting and policy benchmarking on substances of concern and supply chain transparency.
Luxembourg Government Presents First PFAS Report Outlining 40 National Actions
Luxembourg has launched a national PFAS strategy featuring 40 priority actions focused on environmental monitoring, risk reduction, and public transparency. Operators should prepare for intensified oversight of PFAS emissions and potential local restrictions, with trifluoroacetic acid (TFA) singled out as a priority for future regulatory action.
New Mexico Environment Department To Clean Up PFAS-Contaminated Groundwater At Dairies
New Mexico has initiated state-funded PFAS groundwater remediation at local dairies, bypassing federal delays to address contamination from firefighting foam. This proactive state enforcement signals increasing liability risks for PFAS users and sets a precedent for state-led cost recovery against federal or industrial polluters.
Walloon Region Launches Mobile PFAS Biomonitoring Campaign in Affected Zones
Wallonia has launched a mobile PFAS biomonitoring campaign (March–June 2026) to assess blood concentrations in residents of zones previously affected by drinking water contamination. Data from this large-scale screening may increase local pressure for stricter industrial discharge limits and heighten litigation or remediation risks for PFAS-related operations.
Belgian Federal Parliament Rejects PFAS Pesticide Ban; Wallonia Relaunches PFAS Biomonitoring Campaign
The Belgian federal parliament has rejected a proposed ban on PFAS-containing pesticides, while the Walloon Region intensifies human biomonitoring to track exposure from contaminated drinking water. This legislative setback maintains the status quo for agricultural PFAS use, but escalating regional surveillance and water quality standards signal persistent pressure for future restrictions and remediation liabilities.
California Publishes ACE Study on PFAS Exposure From Seafood in Bay Area Asian/Pacific Islanders
California has published a biomonitoring study identifying seafood consumption as a primary exposure route for PFAS in specific Bay Area populations (March 2026). This evidence is expected to drive the development of PFAS-based fish-consumption advisories and increased regulatory scrutiny of PFAS levels in the food supply.
EU SCHEER Working Group on Chemical Mixtures Minutes Published (27 February 2026)
EU scientific advisors are advancing a new framework for chemical mixture risk assessment, focusing on new testing methodologies and regulatory thresholds. This development signals a shift toward more stringent cumulative risk evaluations, likely impacting future compliance requirements for complex product formulations.
Rhode Island Senate Bill S2870 Proposes No-Cost Blood Lead Testing for Young Children
Rhode Island introduced Senate Bill S2870 in March 2026 to mandate no-cost blood lead testing for children and stricter certification for diagnostic laboratories. This proposal signals a continued legislative focus on public health monitoring for heavy metals, potentially increasing administrative oversight for healthcare providers and clinical testing facilities.
Minnesota Legislature Proposes PFAS Biomonitoring Appropriation (HF 3934)
Minnesota has introduced HF 3934 to fund expanded PFAS biomonitoring in metropolitan communities through 2027. Increased state-level data on human exposure will likely drive future litigation risks and stricter regulatory enforcement for PFAS-containing products and industrial emissions.
Delaware HB 312 Proposes Updated Definition of Childhood Lead Testing
Delaware introduced HB 312 to expand the statutory definition of confirmatory childhood lead testing, aligning state diagnostic standards with CDC guidelines. Increased case identification rates under this broader definition may intensify regulatory scrutiny and remediation pressure on lead-containing products and environmental sources.
Netherlands Parliament Questions Health and Cancer Risks Around Chemelot
Dutch parliamentary questions submitted in March 2026 demand increased health surveillance and biomonitoring for residents near the Chemelot chemical complex. This signals rising political pressure for direct human biomonitoring and epidemiological studies, potentially leading to stricter operational oversight and emissions controls for major industrial clusters.
Related topics
Not a newsletter. Not a feed.
Structured intelligence mapped to your business.
These are just a few of the most recent Human Biomonitoring alerts. Foresight tracks every jurisdiction, every day — and surfaces only what affects your portfolio, with full citations and evidence.
Book a demoFrequently asked questions
Everything you need to know about Foresight's regulatory intelligence platform
Still have questions? Get in touch with our team
Join 3,500+ professionals staying ahead
Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.
Free forever. Unsubscribe anytime.
Read by professionals at